Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-06-18

Modelling and predicting sensitivity to targeted therapies in colorectal cancers

Objective

Effective and long term treatment of cancer is now in sight, but will ultimately require an increasingly ‘personalised’ approach where the ‘right’ combination of drugs will be administered to the ‘right’ patients, based on a detailed understanding of their genetic background and their co-associated sensitivity or resistance ‘biomarkers’. Efforts are specifically required to identify validated risk and patient-response stratification criteria, which can then be used to rationally develop companion diagnostic assays and more stream-lined clinical trials. COLTHERES will address these key issues by:
1) Molecularly profiling colon cancer patient samples using multiple ‘omics based technologies for co-segregating lesions that could impart resistance to existing and emerging targeted therapies
2) The building and screening of predictive in vitro models based on this data, to enable the rapid and empirical determination of drug resistance biomarkers
3) The use of these models and of the clinical studies to prospectively screen for genes mediating resistance and sensitivity to targeted therapies in CRCs
4) The building of new algorithms to significantly accelerate the design of rational therapies, by integrating more predictive models, assays and biomarkers into all phases of drug discovery; including novel phase-0 (xenopatients) studies
5) The design of innovative and focused biomarker driven phase II trials based on knowledge gathered within the project

COLTHERES has assembled a unique consortium, from both academia and industrial SMEs, of world- experts in the areas of;
• clinical design of innovative biomarker trials and improved therapeutic strategies
• ‘omics technologies including genomic, transcriptomic, epigenomic and proteomic profiling
• Functional genomic and disease model-generation
• Bio-informatics and data analysis, to handle and interrogate the complexity of the data generated through the various approaches

Call for proposal

FP7-HEALTH-2010-two-stage
See other projects for this call

Coordinator

UNIVERSITA DEGLI STUDI DI TORINO
EU contribution
€ 1 507 200,00
Address
VIA GIUSEPPE VERDI 8
10124 Torino
Italy

See on map

Region
Nord-Ovest Piemonte Torino
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Alberto Bardelli (Prof.)
Links
Total cost
No data

Participants (10)